key: cord-0884588-85mz0l7h authors: Erol, Adnan title: Are the emerging SARS-COV-2 mutations friend or foe? date: 2021-01-02 journal: Immunol Lett DOI: 10.1016/j.imlet.2020.12.014 sha: a614abb3b8b083d26411d4e776ee217b6c13c012 doc_id: 884588 cord_uid: 85mz0l7h • Current two important SARS-CoV-2 variants are D614 G and N501Y. • They cause S1 of the spike protein to open conformation. • Open conformation may increase the transmissibility of the virus. • Open conformation may also increase the immunogenicity of the S1 epitopes. current concern for most vaccines being implemented around the world. The novel UK variant, known as VUI-2020/01 or lineage B.1.1.7 carries 14 defining mutations in the spike protein [1] . This variant has a mutation in the RBD of the spike protein at position 501, where amino acid asparagine (N) has been replaced with tyrosine (Y). N501Y mutation, which is one the key six contact residues within the RBD, increases the binding affinity of virus to ACE2 receptor [13] . Another mutation at position 681, P681H, which is immediately adjacent to the furin cleavage site renders it more suitable for hydrolysis by TMPRSS2 and thus augmenting the viral fusion [14] . Since N501Y and P681H were previously observed independently, the UK variant is important as it contains both N501Y and P681H in combination. Remarkably, this new variant also carries a deletion mutation in another viral gene, ORF8, which was previously associated with a milder clinical infection and less post-infection inflammation [1, 15] . Many mutations to the RBD are well tolerated with respect to both protein folding and ACE2 binding, which are two key factors for viral fitness. However, the ACE2 binding interface is more constrained than most of the RBD's surface, which could limit viral escape from antibodies that target this interface. N501Y variant shows a doubling of the occupancy of the open state with the concomitant decrease of the closed state [16] . Therefore, N501Y has a strong potential to contribute to increased transmission [17] . However, an increase in the open state of N501Y variant may also augment the antibody neutralization of the virus. In the light of these data regarding the two important SARS-CoV-2 variants, the points to be emphasized can be listed as follows. 1 In the ancestral virus (SARS-CoV-2 D634 and N501), RBD is in down conformation, which means the receptor is in more stable and inaccessible state. Consequently, the old variant demonstrates higher resistance to the host immunity, comparing the new variants. In other words, while the ancestral SARS-CoV-2 is in the most stable and immune-resistant conformation, emerging mutations would limit the immune evasive features of the virus and cause it to become more easily controllable. 2 These new mutations clearly provide a fitness advantage for transmission. However, relatively better-concealed D614 receptor-binding domain of old variant is likely to be advantageous for immune evasion. Hence, there would be most probable fitness tradeoffs for D614 G and N501Y due to the more open conformation of its RBD, which potentially renders these new variants more immunogenic. 3 The deletion mutation of ORF8 in the most recent UK variant may cause a milder clinical infection and less post-infection inflammation as happened in Singapore [15] . 4 The current evidence suggests that these mutations are less important for COVID-19 than other risk factors, such as age or comorbidities [5] . Therefore, if patients in the risk group can be better protected, while new SARS-CoV-2 mutations increase the transmission of infection, they become vulnerable to natural or vaccine-induced immunity that, in turn, may promote the faster development of herd immunity. 5 Finally, the bat virus RaTG13, which was identified as the closest known relative of SARS-CoV-2, has substantially lower affinity for ACE2 than SARS-CoV-2 because of the presence of affinity-decreasing mutation of N501D [6] . Hence, it would not be surprising to expect the possibility of the N501D variant instead of N501Y during future mutations and therefore the virus to self-inactivate. In conclusion, although it is absolutely required to wait for the results of clinical and epidemiological data, we could hope for a better future instead of being pessimistic due to current mutations. Preliminary Genomic Characterisation of an Emergent SARS-CoV-2 Lineage in the UK Defined by a Novel Set of Spike Mutations Thinking outside the triangle: replication fidelity of the largest RNA viruses Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus Making sense of mutation: what D614G means for the COVID-19 pandemic remains unclear SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects Functional importance of the D614G mutation in the SARS-CoV-2 spike protein Spike mutation D614G alters SARS-CoV-2 fitness D614G spike mutation increases SARS CoV-2 susceptibility to neutralization SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding The Insert Sequence in SARS-CoV-2 Enhances Spike Protein Cleavage by TMPRSS, bioRxiv Prepr Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy Modelling Conformational State Dynamics and Its Role on Infection for SARS-CoV-2 Spike Protein Variants, bioRxiv Prepr